CLINICAL AND ECONOMIC BENEFITS OF NATIONAL IMMUNIZATION WITH THE 13-VALENT COMPARED TO 7-AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN GREECE

被引:1
|
作者
Papanicolaou, S.
Kontodimas, S. [1 ]
Syriopoulou, V
Tsolia, M. [2 ]
Theodoridou, M. [2 ]
Strutton, D. R. [3 ]
Hwang, S. [3 ]
Tzanakaki, G. [4 ]
Kremastinou, J. [4 ]
Earnshaw, S. R. [5 ]
Farkouh, R. [5 ]
Karokis, A. [6 ]
Konstantopoulos, A.
机构
[1] Wyeth Hellas SA, Athens, Attika, Greece
[2] Univ Athens, Sch Med, GR-11527 Athens, Greece
[3] Wyeth Res, Collegeville, PA USA
[4] Natl Sch Publ Hlth, Athens, Greece
[5] RTI Hlth Solut, Res Triangle Pk, NC USA
[6] Wyeth, Athens, Greece
关键词
D O I
10.1016/S1098-3015(10)75093-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A423 / A424
页数:2
相关论文
共 50 条
  • [1] Pneumococcal immunization with conjugate vaccines: are 10-valent and 13-valent vaccines similar?
    Esposito, Susanna
    Principi, Nicola
    [J]. FUTURE MICROBIOLOGY, 2019, 14 (11) : 921 - 923
  • [2] Pneumococcal immunization with conjugate vaccines - are 10-valent and 13-valent vaccines similar?
    Vyse, Andrew
    Theilacker, Christian
    Sings, Heather
    Fletcher, Mark
    [J]. FUTURE MICROBIOLOGY, 2020, 15 (08) : 575 - 578
  • [3] Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease
    Theilacker, Christian
    Hilton, Betsy
    Jiang, Qin
    Gessner, Bradford D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) : 1641 - 1642
  • [4] Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
    Kim, Hye-Young
    Park, Seong-Beom
    Kang, Eun-Sil
    Lee, Sang-Min
    Kim, Hyun-Jin
    Wasserman, Matt
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 909 - 918
  • [5] Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease Reply
    Naucler, Pontus
    Galanis, Ilias
    Morfeldt, Eva
    Darenberg, Jessica
    Ortqvist, Ake
    Henriques-Normark, Birgitta
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) : 1642 - 1643
  • [6] Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India
    Ghia, Canna J.
    Horn, Emily K.
    Rambhad, Gautam
    Perdrizet, Johnna
    Chitale, Ramaa
    Wasserman, Matt D.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2271 - 2288
  • [7] The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease
    Principi, Nicola
    Esposito, Susanna
    [J]. EXPERT REVIEW OF VACCINES, 2015, 14 (10) : 1359 - 1366
  • [8] Correction to: Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India
    Canna J. Ghia
    Emily K. Horn
    Gautam Rambhad
    Johnna Perdrizet
    Ramaa Chitale
    Matt D. Wasserman
    [J]. Infectious Diseases and Therapy, 2021, 10 : 2289 - 2289
  • [9] Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines
    Tyo, Karen Richards
    Rosen, Melissa M.
    Zeng, Wu
    Yap, Mabel
    Pwee, Keng Ho
    Ang, Li Wei
    Shepard, Donald S.
    [J]. VACCINE, 2011, 29 (38) : 6686 - 6694
  • [10] Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe
    Hanquet, Germaine
    Krizova, Pavla
    Dalby, Tina
    Ladhani, Shamez N.
    Nuorti, J. Pekka
    Danis, Kostas
    Mereckiene, Jolita
    Knol, Mirjam J.
    Winje, Brita A.
    Ciruela, Pilar
    de Miguel, Sara
    Eugenia Portillo, Maria
    MacDonald, Laura
    Morfeldt, Eva
    Kozakova, Jana
    Valentiner-Branth, Palle
    Fry, Norman K.
    Rinta-Kokko, Hanna
    Varon, Emmanuelle
    Corcoran, Mary
    van der Ende, Arie
    Vestrheim, Didrik F.
    Munoz-Almagro, Carmen
    Sanz, Juan-Carlos
    Castilla, Jesus
    Smith, Andrew
    Henriques-Normark, Birgitta
    Colzani, Edoardo
    Pastore-Celentano, Lucia
    Savulescu, Camelia
    [J]. EMERGING INFECTIOUS DISEASES, 2022, 28 (01) : 127 - 138